Liver Fat, Iron, Fibrosis, (and T1): Quantitative MRI in Chronic Liver Disease

By UCSF School of Medicine FEATURING Michael A. Ohliger

181 views

October 10, 2024

Comments 0

MAFLD: What Is It?

Houston Methodist

D. Victor

9.9K views

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

3.9K views

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

1.7K views

Current Treatment of Metabolic Dysfunction Associated with Steatotic…

Indiana University School of Medicine Division of Gastroenterology and Hepatology

N. Samala

103 views

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

2.8K views

Acute Arterial Conditions of the Pancreas: The IR Perspective

UChicago Medicine

J. Lorenz

351 views

Caring for the Post Liver Transplant Patient in the Primary Care Set…

University of Colorado Department of Medicine

B. Henderson, M. O'Meara

171 views

Heart and Liver Interactions

Houston Methodist DeBakey Heart and Vascular Center

S. Adeel Ahsan

56 views

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

3.6K views

Medical Management of Metabolic Associated Steatotic Liver Disease

Michigan Medicine

R. Fontana

57 views

NASH Update 2023

Icahn School of Medicine at Mount Sinai

M. B. Bansal

176 views

The Evolving Landscape of Non-Alcoholic Fatty Liver Disease (NAFLD) …

Cardiometabolic Health Congress (CMHC)

K. Cusi

58 views

Fatty Liver Disease: When to Refer?

Yale School of Medicine

1.7K views

NAFLD: Updates in Management

UChicago Medicine

M. E. Rinella

1.8K views

Practice Guidelines Based Approach to Hereditary Hemochromatosis

MUSC Health

K. Kowdley

250 views

Updates on Management of NASH

Pennsylvania Society of Gastroenterology

T. Singh

1.0K views

New Treatments for Steatotic Liver Disease (SLD): Are We There Yet?

University of Miami

S. A. Harrison

60 views

Non-Alcoholic Fatty Liver Disease: Where Are We in 2023?

Houston Methodist

N. Gunn